E. Chan, E. Hyzny, Masashi Furukawa, J. Luketich, P. Sanchez
{"title":"Management of blind-end subglottic stenosis following SARS-CoV-2 infection: a case report","authors":"E. Chan, E. Hyzny, Masashi Furukawa, J. Luketich, P. Sanchez","doi":"10.21037/shc-21-23","DOIUrl":null,"url":null,"abstract":"Background: Reports identify rates of prolonged intubation as high as 28% in patients who are hospitalized for worsening respiratory status due the SARS-CoV-2 infection. This has placed a toll on healthcare systems around the world. However, we believe we are only seeing the beginnings of complications associated with the COVID-19 pandemic. Subglottic tracheal stenosis is a known complication of prolonged intubation and may therefore be on the rise in the wake of the current pandemic. The European Laryngology Society created the Laryngotracheal Stenosis Committee to alert the international medical community of the rise in airway complications associated with long-Term intubation and high rates of tracheostomy seen in the recent months during the pandemic. Optimal surgical management of the unique features of subglottic stenosis following COVID-19 disease, especially in severely deconditioned patients, has yet to be reported. Case Description: We report the surgical management of blind-end Myer-Cotton Grade IV subglottic stenoses in two patients who required prolonged mechanical ventilatory support for respiratory failure resulting from the SARS-CoV-2 infection with a two stage minimally invasive recanalization strategy. Patients underwent two-step minimally invasive process for recanalization. The first step is to re-establish a patent tracheal lumen under direct visualization utilizing both a rigid bronchoscope from proximally as well as a flexible bronchoscope distal to the stenosis from the tracheostomy stoma. Once the tracheal lumen is re-established, proper dilation of the airway and hemostasis is achieved in standard fashion. Both patients have had roughly 6 months of follow-up and have tolerated their silicone T-Tubes capped at all times. Neither patient currently require any oxygen supplementation and continue to phonate well. While they are not at their baseline in terms of physical activity, they are continuing their rehabilitation process. Conclusions: While the definitive treatment continues to be surgical resection, the endoscopic approach to re-establishing the tracheal lumen is a safe and effective method with little to no morbidity and mortality. This will allow for uninhibited rehabilitation following prolonged mechanical ventilatory support and hospital stay following severe COVID-19 infection. © 2022 Audiology and Speech Research. All rights reserved.","PeriodicalId":74794,"journal":{"name":"Shanghai chest","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shanghai chest","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/shc-21-23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
SARS-CoV-2感染后盲端声门下狭窄的治疗1例
背景:报告发现,在因严重急性呼吸系统综合征冠状病毒2型感染导致呼吸系统状况恶化而住院的患者中,延长插管的比率高达28%。这给世界各地的医疗系统带来了损失。然而,我们认为,我们只看到了与新冠肺炎大流行相关的并发症的开始。声门下气管狭窄是长期插管的一种已知并发症,因此在当前的疫情之后可能会增加。欧洲喉科学会成立了喉气管狭窄委员会,以提醒国际医学界,在疫情期间的近几个月里,与长期插管和高气管切开率相关的气道并发症有所增加。新冠肺炎疾病后声门下狭窄独特特征的最佳手术治疗,尤其是在严重病情缓解的患者中,尚待报道。病例描述:我们报告了两名因严重急性呼吸系统综合征冠状病毒2型感染导致呼吸衰竭而需要长期机械通气支持的患者的盲端Myer Cotton IV级声门下狭窄的手术治疗,采用两阶段微创再通策略。患者接受了两步微创再通术。第一步是利用近端的刚性支气管镜和气管造口术口狭窄远端的柔性支气管镜,在直接可视化的情况下重新建立通畅的气管管腔。一旦重建了气管管腔,就可以以标准的方式实现气道的适当扩张和止血。这两名患者都接受了大约6个月的随访,并一直耐受他们的硅胶T型管。目前,两名患者都不需要任何氧气补充,并且继续保持良好的发音。虽然他们的身体活动还没有达到基线,但他们正在继续康复过程。结论:虽然最终的治疗方法仍然是手术切除,但内镜下重建气管管腔是一种安全有效的方法,发病率和死亡率很低甚至没有。这将允许在长期机械通气支持后进行无限制的康复,并在严重新冠肺炎感染后住院。©2022听力学与言语研究。保留所有权利。
本文章由计算机程序翻译,如有差异,请以英文原文为准。